Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics and safety of free- and fixed-dose combinations of Singulair (montelukast) and Xyzal (levocetirizine) for rhinitis has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Drugs mentioned

• SINGULAIR (montelukast)
• XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Rhinitis | Phase 1 | Status: COMPLETED